Obesity, Metabolic Syndrome & Breast Cancer – short review

Authors

  • Nadia Islam

DOI:

https://doi.org/10.37868/bes.v2i1.id182

Abstract

Breast cancer is the leading cause of death among women and the second largest cause of mortality in the entire population worldwide. This review investigated how breast cancer is patho-physiologically associated with obesity which is defined by body mass index ≥30 kg/  and metabolic syndrome which leads to type 2 diabetes in pre and postmenopausal women. It also addressed the controversy relating the definition of BMI. The biological markers in breast cancer currently in use are ER, PR, HER2, uPA, and PAI-1. This study looked into future of predictive and prognostic biomarkers, such as exosome by altering interaction of distant cancer cells in the tumor microenvironment and the breast cancer progress.

Downloads

Published

2021-06-30

How to Cite

[1]
N. Islam, “Obesity, Metabolic Syndrome & Breast Cancer – short review”, Bioengineering Studies, vol. 2, no. 1, pp. 46–54, Jun. 2021.

Issue

Vol. 2 No. 1 (2021)

Section

Articles

License

Copyright (c) 2021 Nadia Islam

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

This journal permits and encourages authors to post items/PDFs submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.